Diabetes - Page 9

June 23

Diabetic patients taking GLP-1s may face increased risk of eye disease, study suggests

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure increasing danger of macular degeneration.

June 21

Grandfather's simple changes reversed pre-diabetes diagnosis that left him 'petrified'

After a shocking pre-diabetes diagnosis, an active grandfather transformed his health by eating slower and making better food choices, lowering blood sugar levels and losing 27 pounds.

June 11

Dr. Pepper Zero Sugar recall upgraded as FDA warns of serious health risk for diabetics

Mislabeled Dr. Pepper Zero Sugar cans affect over 19,000 cases with full sugar content, creating potential health concerns for consumers with sugar restrictions.

June 10

Who should be taking weight-loss drugs? Doctors share best candidates

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk and potential applications for addiction treatment.

May 28

Hoda Kotb reveals daughter's concerning diagnosis influenced her exit from 'Today'

Hoda Kotb discusses leaving "The Today Show" to focus on her daughter Hope's type 1 diabetes, emphasizing the importance of spending time with family and managing her child's health.

May 23

Doctors warn of 'trifecta' of chronic illnesses plaguing Americans after MAHA report

Chronic diseases such as obesity, diabetes and hypertension affect 133 million Americans, with the MAHA Commission urging action on better nutrition and diet.

May 17

Weight loss, diabetes drugs can cause mood changes: What to know about behavioral side effects

Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing mood and personality changes.

May 3

Semaglutide found to have shocking benefit for liver disease patients in new study

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of patients and offering new hope for those with the life-threatening condition.

April 17

First GLP-1 pill for weight loss, diabetes shows success in late-phase trial

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type 2 diabetes. Previous versions were administered via injection.

April 16, 2025

Diabetes risk linked to these ultraprocessed food combinations

A new study found that certain combinations of food additives are linked to a higher chance of developing type 2 diabetes. Experts discuss how to mitigate risk.